Expanded polytetrafluoroethylene (ePTFE) vascular graft loses its thrombogenicity six months after implantation

Thrombosis Research

Volumn 88, Issue 5, 1997, Pages 427-433

  Ariyoshi, Hideo ^a   Okuyama, Masaki ^a   Okahara, Kazuhiro ^a   Kawasaki, Tomio ^a   Kambayashi, Jun Ichi ^a   Sakon, Masato ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Expanded polytetrafluoroethylene grafts; Thrombin antithrombin III complex

Indexed keywords

ANTITHROMBOCYTIC AGENT; C REACTIVE PROTEIN; D DIMER; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; WARFARIN;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTICLE; BLOOD VESSEL GRAFT; FEMALE; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POLITEF IMPLANT; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOGENICITY;

EID: 0031446986     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00278-8     Document Type: Article

References (26)

1. Matsumoto H, Hasegawa T, Fuse K. A new vascular prosthesis for a small-caliber artery. Surgery 1973;74:519-23.
2. Campbell CD, Goldfarb D, Rodney RA. Small arterial substitute: Expanded microporus polytetrafluoroethylene: Patency vs porosity. Ann Surg 1975;182:138-43.
3. Muller KM, Dasbach G. The pathology of vascular grafts. Curr Topics Pathology. 86:1994;273-306.
4. Camilleri JP, Phat VN, Bruneval P. Surface healing and histological maturation of patent polytetrafluoroethylene grafts implanted in patients for up to 60 months. Arch Pathol Lab Med 1985;109:833-7.
5. Guidon R, Chakfe N, Maurel S. Expanded polytetrafluoroethylene arterial prosthesis in humans: Histopathological study of 298 surgically excised grafts. Biomaterials 1993;14:678-93.
6. Formichi MJ, Guidoin RG, Jausseran JM Expanded PTFE prosthesis as arterial substitute in humans: Late pathological findings in 73 excised grafts. Ann Vasc Surg. 2:1998;14-26.
7. Pelzer H, Schwarz A, Heimburger N. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 1988;59:101-6.
8. Rylatt DB, Blake AS, Cottis LE. An immuno-assay for human D-dimer using monoclonal antibodies. Thromb Res 1983;31:767-72.
9. Bailey EL, Harper TA. Therapeutic range of one-stage prothrombin time in control of anti-coagulant therapy. CMAJ 1971;105:1041-8.
10. Campbell CD, Brooks DH, Webster MW, Diamond DL, Peel RL, Bahnson HT. Expanded microporous polytetrafluoroethylene as a vascular substitute. Surgery 1979;85:177-83.
11. Suy R, Nevelsteen A, Deleersnijder D. The expanded polytetrafluoroethylene (PTFE) graft as a vascular substitute. J Cardiovasc Surgery 1980;21:321-8.
12. Weisel RD, Johnston KW, Baird RJ, Drezner AD, Oates TK, Lipton IH Comparison of conduits for leg revasculization. Surgery. 89:1981;8-15.
13. Yeagerm RA, Hobson RW II, Lynch TG Analysis of factors influencing patency of polytetrafluoroethylene prosthesis for limb salvage. J Surg Res. 32:1982;499-506.
14. Campbell CD, Goldfarb D, Roe R. A small arterial substitute. Ann Surg 1975;182:138-43.
15. Bellon JM, Bujan J, Hernand N, Honduvilla NG, Jurado F Arterial autografts and PTFE vascular microprosthesis: Similarities in the healing process. Eur J Vasc Surg. 8:1994;694-702.
16. Esquivel O, Bjorck CG, Bergentz SE. Reduced thrombogenic characteristics of expanded polytetrafluoroethylene and polyurethane arterial grafts after heparin bonding. Surgery 1984;95:102-7.
17. Sauvage LR, Berger KE, Wood SJ, Yates SG II, Smith JC, Mansfield PB Interspecies healing of porus arterial prosthesis. Arch Surg. 109:1974;698-705.
18. Nichter LS, Bindiger A. Improving micrograft patency. Microsurgery 1998;9:235-41.
19. Johnson PC. Platelet-mediated thrombosis in microvascular surgery: New knowledge and strategies. Plast Reconst Surg 1990;86:359-67.
20. Larsson R, Friksson JG, Lagergren H, Olsson P. Platelet and plasma coagulation compatibility of heparinized and sulphated surfaces. Thromb Res 1979;15:157-67.
21. Nossel HL. Interface-induced coagulation reactions. In: Sawer PN, Kaplitt MJ, editors. Vascular Grafts. New York: Appleton-Century-Crofts; 1978. pp. 108-12.
22. Griffin JH The role of surface in the surface-dependent activation of Hargeman factor (Factor XII). Proc Natl Acad Sci USA. 75:1978;1998-2001.
23. Kang J, Kambayashi J, Sakon M, Tsujinaka T, Mori T. Postoperative changes in hemostasis analyzed by the serial determination of fibrinopeptides and D-dimer. Jpn J Surg 1989;19:262-8.
24. Ikeda M, Ariyoshi H, Kambayashi J, Sakon M, Kawasaki T, Monden M Simultaneous digital imaging analysis of cytosolic calcium and morphological change in platelets activated by surface contact. J Cell Biochem. 61:1996;292-300.
25. Lindon JN, McManama G, Kushner L, Salzman EW. Does the conformation of adsorbed fibrinogen dictate platelet-surface interactions? Blood 1986;68:535-9.
26. Merrill EW, Salzman EW, Wong PSL. Polyvinyl alcohol-heparin hydrogel "G". J Appl Physiol 1972;29:723-6.